Can Pulmonary Embolism Cause Heart Failure?
Yes, pulmonary embolism can directly cause acute right ventricular failure and, less commonly, left ventricular systolic dysfunction, though it more often exacerbates pre-existing heart failure rather than causing chronic heart failure de novo.
Mechanisms of PE-Induced Cardiac Dysfunction
PE causes heart failure through distinct pathophysiological mechanisms:
Right Ventricular Failure (Primary Mechanism)
The right ventricle is designed for low-resistance afterload. When acute PE increases pulmonary vascular resistance, the RV cannot accommodate this sudden pressure overload, leading to:
- Acute RV dilation and dysfunction
- Hemodynamic compromise
- Potential cardiovascular collapse 1
Approximately 45% of patients with acute PE develop acute right ventricular failure 1. This is the dominant cardiac complication and explains why massive PE—defined as acute PE with sustained hypotension (systolic BP <90 mmHg for ≥15 minutes), pulselessness, or persistent profound bradycardia—carries such high mortality 2.
Left Ventricular Dysfunction (Less Common)
Recent evidence demonstrates that 10.5% of acute PE patients present with LV systolic dysfunction 3. Importantly, this can occur even in patients without prior cardiac disease:
- Younger patients without cardiac history can develop acute LV dysfunction during massive PE
- These patients show improvement in ejection fraction after PE treatment (median improvement 20%)
- Patients with pre-existing cardiac disease show minimal recovery (median improvement 0%) 3
Clinical Severity and Outcomes
The relationship between PE severity and heart failure risk follows a clear gradient:
Massive PE (hemodynamically unstable):
- 25% in-hospital mortality with cardiogenic shock
- 65% mortality if requiring cardiopulmonary resuscitation 2
Submassive PE (RV dysfunction without hypotension):
- Intermediate risk based on echocardiographic RV dysfunction and biomarkers 2
PE in Pre-existing Heart Failure: When PE complicates existing severe decompensated heart failure, it acts as an independent predictor of adverse outcomes:
- 72.2% death or rehospitalization at 3 months (vs. 43.9% without PE)
- Longer hospital stays (37.5 vs. 15.4 days)
- 4-fold increased odds of death or rehospitalization 4
Chronic Sequelae
Up to 3.8% of PE patients develop chronic thromboembolic pulmonary hypertension (CTEPH), which leads to progressive, severe chronic heart failure 1. This represents true chronic heart failure caused by PE.
Key Clinical Pitfalls
Diagnostic Confusion: PE and acute heart failure share overlapping presentations (dyspnea, elevated D-dimer, elevated troponin and BNP). In AF patients, elevated D-dimer can be falsely positive for PE when the actual diagnosis is worsening heart failure 5.
Undertreatment: Despite guidelines recommending systemic thrombolysis for hemodynamically unstable PE, fewer than 25% of appropriate patients receive it 6. This represents a critical treatment gap given the high mortality.
Bidirectional Risk: While PE can cause heart failure, pre-existing heart failure is also a well-recognized risk factor for developing PE, creating a vicious cycle 7, 8.
Prognostic Context
When properly diagnosed and treated with anticoagulation, only 2.5% of PE patients die from PE itself 8. Most deaths (95 patients, 23.8% at one year) result from underlying conditions like cancer, infection, or cardiac disease 8. However, this favorable prognosis requires prompt recognition and treatment—the 8.3% who experience recurrent PE have a 45% mortality rate 8.
The critical determinant is hemodynamic status at presentation: hypotension identifies patients at dramatically elevated risk who require aggressive intervention including consideration of thrombolysis or catheter-directed therapy 2, 9.